Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Dificid (fidaxomicin) – Narrow-Spectrum Antibiotic for Clostridium Difficile Infection

Proposed interaction site of fidaxomicin, indicated by an arrow, based on sequencing data of laboratory generated <i>Clostridium difficile</i> mutants.



Go Top